1) Endo H, Fujimura M, Niizuma K, Shimizu H, Tominaga T:Efficacy of revascularization surgery for moyamoya syndrome associated with Graves' disease. Neurol Med Chir(Tokyo)50:977-983, 2010
2) Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T:Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67:273-282, 2007
3) Fujimura M, Shimizu H, Mugikura S, Tominaga T:Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease:possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol 71:223-227, 2009
4) Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T:Incidence and risk factors for symptomtic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 71:442-447, 2009
5) Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, Tominaga T:Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery 74:163-170, 2014
6) Fujimura M, Tominaga T:Significance of cerebral blood flow analysis in the acute stage after revascularization surgery for moyamoya disease. Neuro Med Chir(Tokyo)55:775-781, 2015
7) Hayashi K, Horie N, Suyama K, Nagata I:Incidence and clinical features of symptomatic cerebral hyperperfusion syndrome after vascular reconstruction. World Neurosurg 78:447-454, 2012
8) 林 智秀,柏崎大奈,秋岡直樹,桑山直也,黒田 敏:術後過灌流が再燃して症候化したと考えられる成人もやもや病の1例.No Shinkei Geka 42:621-627, 2014
9) 宝金清博,野中 雅,馬場雄大:モヤモヤ病の外科治療の周術期リスク,pp47-50.厚生労働科学研究費補助金難治性疾患克服研究事業 モヤモヤ病(ウィリス動脈輪閉塞症)に関する調査研究,平成16年度総括・分担研究報告書(2005年3月)
10) Im SH, Oh CW, Kwon OK, Kim JE, Han DH:Moyamoya disease associated with Graves disease:special considerations regarding clinical significance and management. J Neurosurg 102:1013-1017, 2005
11) Kushima K, Satoh Y, Ban Y, Taniyama M, Ito K, Sugita K:Graves' thyrotoxicosis and Moyamoya disease. Can J Neurol Sci 18:140-142, 1991
12) 松本 香,野垣 宏,山本 清,佐々部富士男,森松光紀:Basedow病を合併したモヤモヤ病の1例.脳卒中14:409-413, 1992
13) 三上 毅,杉野寿哉,菅野 彩,宝金清博,三國信啓:甲状腺機能亢進症に合併した類もやもや病.脳卒中34:82-88, 2012
14) Nakamura K, Yanaka K, Ihara S, Nose T:Multiple intracranial arterial stenoses around the circle of Willis in association with Graves' disease:report of two cases. Neurosurgery 53:1210-1215, 2003
15) Ohba S, Nakagawa T, Murakami H:Concurrent Graves' disease and intracranial arterial stenosis/occulusion:special considerations regarding the state of thyroid function, etiology, and treatment. Neurosurg Rev 34:297-304, 2011
16) Ryu B, Kawamata T, Yamaguchi K, Kawashima A, Ono M, Okada Y:Moyamoya disease concurrent with Graves' disease treated by direct bypass:clinical features and treatment strategies. Acta Neurochir(Wien)157:1095-1102, 2015
17) Tendler BE, Shoukri K, Malchoff C, MacGillivray D, Duckrow R, Talmadge T, Ramsby GR:Concurrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety. Thyroid 7:625-629, 1997
18) 若本寛起,石山直巳,宮崎宏道,篠田淳男,冨田栄幸:Basedow病の治療に伴い脳主幹動脈の狭窄が改善した1例.No Shinkei Geka 28:379-383, 2000